Management of Ureaplasma in Urine

Clinical Context Determines Management

• The American College of Physicians and the Infectious Diseases Society of America recommend not treating asymptomatic Ureaplasma detected in urine, as asymptomatic bacteriuria should not be treated in most clinical scenarios, except in pregnant women and before endoscopic urologic procedures with mucosal trauma 1, 2
• The European Association of Urology guidelines recognize U. urealyticum (but not U. parvum) as a causative agent of non-gonococcal urethritis, which causes 20-40% of non-gonococcal urethritis cases 3, 4

Symptomatic Urethritis (Treatment Indicated)

• The Centers for Disease Control and Prevention recommend treating urethritis symptoms (dysuria, urethral discharge, urethral pruritus) with doxycycline 100 mg orally twice daily for 7 days 3, 5
• Alternative regimens if doxycycline cannot be used include erythromycin base 500 mg orally 4 times daily for 7 days 3

Special Populations

• The European Association of Urology guidelines recommend evaluating and treating all at-risk sexual partners when treating urethritis, with the same treatment regimen even if asymptomatic 3, 5, 4, 6

Common Pitfalls to Avoid

• The Infectious Diseases Society of America recommends not treating Ureaplasma found incidentally on urine culture without corresponding symptoms 1, 2
• The European Association of Urology guidelines recommend not confusing U. urealyticum with U. parvum—only U. urealyticum is definitively pathogenic in urethritis 5, 4

Treatment of Ureaplasma in Urine

First-Line Treatment for Symptomatic Urethritis

• The European Association of Urology recommends doxycycline 100 mg orally twice daily for 7 days as the first-line treatment for symptomatic urethritis caused by Ureaplasma 7
• Azithromycin 1.0-1.5 g orally as a single dose is an alternative regimen for symptomatic urethritis caused by Ureaplasma 7

Treatment of Sexual Partners

• The European Association of Urology guidelines suggest that all at-risk sexual partners should be evaluated and treated with the same regimen, even if asymptomatic, to prevent reinfection 7
• Patient confidentiality must be maintained during partner notification, as recommended by the European Association of Urology 7

Common Pitfalls to Avoid

• Unnecessary antibiotic exposure and resistance development can occur when treating Ureaplasma found incidentally on urine culture without corresponding symptoms, as noted in European Urology 8
• Eradication of potentially protective commensal organisms can occur when treating asymptomatic Ureaplasma bacteriuria, as reported in European Urology 8

Resistant or Persistent Infections

• The European Association of Urology guidelines recommend considering azithromycin 500 mg on day 1, then 250 mg daily for 4 days as second-line treatment for persistent symptoms after initial doxycycline therapy 7
• For macrolide-resistant strains, moxifloxacin 400 mg daily for 7-14 days may be used, as suggested by the European Association of Urology 7